{{Rsnum
|rsid=2319125
|Gene=CEP112
|Chromosome=17
|position=66102427
|Orientation=plus
|GMAF=0.2571
|Gene_s=CEP112
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 28.2 | 47.3 | 24.5
| HCB | 0.0 | 17.0 | 83.0
| JPT | 0.0 | 7.2 | 92.8
| YRI | 2.1 | 23.6 | 74.3
| ASW | 0.0 | 28.6 | 71.4
| CHB | 0.0 | 17.0 | 83.0
| CHD | 0.0 | 4.6 | 95.4
| GIH | 7.1 | 39.8 | 53.1
| LWK | 1.8 | 32.1 | 66.1
| MEX | 5.2 | 36.2 | 58.6
| MKK | 1.3 | 25.0 | 73.7
| TSI | 14.9 | 51.5 | 33.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23279374
  |Trait=β2-Glycoprotein I (β2-GPI) plasma levels
  |Title=Genetic determinants of plasma β2 -glycoprotein I levels: a genome-wide association study in extended pedigrees from Spain.
  |RiskAllele=C
  |Pval=1E-6
  |OR=.42
  |ORtxt=(unit increase)
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}